Beauty / Health  
Select Category:

OBAGI® Adds a New Length to the Science of Eyelash Enhancing with ELASTILash™
 Print this page

Nov 30, 2010
OBAGI® Adds a New Length to the Science of Eyelash Enhancing with ELASTILash™ by Sandra J. Freer

For Immediate Release: Windsor, Ontario, Canada

RGR Pharma Ltd. announces the addition of ELASTILash™ solution to the OBAGI® family of skin care products.

The mission to find a safe and easy to apply eyelash solution that achieves the appearance of thicker, fuller eyelashes has been an interest for many women. The product should be easy to use, safe for all eye colours and skin colours; it should not have any temporary or permanent side effects; it should be non-allergenic and hopefully priced under $100.00.

Is all of this possible ?

ELASTILash™ has been solely developed as a unique eyelash enhancer that will help achieve the appearance of visibly thicker, fuller-looking eyelashes. Seven out of ten patients reported the appearance of thicker fuller lashes in as little as 4 to 6 weeks.

OBAGI® is well known and trusted for their science of maintaining good skin health, as well as their commitment to both safe and effective products, and now, - the science of eyelash enhancing.

ELASTILash™ joins ELASTIderm™ - the aesthetically elegant eye cream or gel, clinically proven to help replenish elastin and build collagen in the sensitive skin around the eye area; along with ELASTIderm™ Decolletage System to restore and maintain the radiant, youthful glow of your chest (décolletage) and neck - the only skincare system designed to reduce age spots, hyperpigmentation (discoloration), visible fine lines and wrinkles on your delicate chest and neck area.

ELASTILash™, formulated with Myristoyl Pentapeptide-17, a peptide with a proprietary blend of ingredients penetrates the eyelash hair follicles and stimulates eyelash growth. Convenient to purchase directly from your aesthetic skin care specialist; the ELASTILash™ eyelash solution is the much sought after answer for an eyelash stimulator. Clinical trials have shown the efficacy of this product as also safe for sensitive eyes and contact lens wearers. Dermatologist and Ophthalmologist tested (1.) Non-allergenic, Non-irritating and No-evidence of eyelid darkening, No-change in Iris, No-evidence of developing eye cysts, No-itching, No-irritation, No-prostaglandins (adverse side effects).

Plus, there is No-need to change the wand with every application.

ELASTILash™ answers the need from the individuals affected by thin, sparse eyelashes who previously relied on false eyelashes or eyelash extensions. The added benefit is that ELASTILash™ has been known to help strengthen eyelashes.

ELASTILash™ comes in a mascara-type applicator with an eyeliner-type brush tip for application. Directions for use are only two steps: Wash your hands thoroughly with soap and water. Ensure the upper eyelid area skin is clean and dry before applying the product. Apply a generous brush stroke of ELASTILash™ Eyelash Solution along the entire upper eyelash line only, once per day before going to bed. ELASTILash™ does not require the wand to be changed with each application.

Exceptionally well priced at approximately $72.00 CDN.— and lasting an average of 3 months — the mission is accomplished

About OBAGI® Medical Products, Inc.

OBAGI® Medical Products is a specialty pharmaceutical company that develops, markets and sells. And is a leading provider of proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market. Using its Penetrating Therapeutics ™ technologies, Obagi® Medical's products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, rosacea, and soft tissue deficits, such as fine lines and wrinkles.

The history of OBAGI's skin care product introductions is as follows: OBAGI® Nu-Derm®, 1988; OBAGI® -C® Rx (the first and only prescription-strength vitamin C system), 2004; OBAGI ® Professional-C (a line of highly stable vitamin C serums), 2005; OBAGI® (Condition and Enhance for use with cosmetic procedures to enhance patient outcomes and satisfaction, 2006; OBAGI® ELASTIderm™ Eye Treatment and the OBAGI ® CLENZIderm ® acne therapeutic systems, 2007; a formulation of OBAGI® CLENZIderm ®M.D. Systems for normal to dry skin, June 2007; OBAGI ®ELASTIderm ™ Decolletage System, January 2008; OBAGI ® Rosaclear ™System in January 2009 and ELASTILash ™ eyelash solution, October 2010. Please Visit www.obagi.com for more information.

About: RGR Pharma Inc.

RGR Pharma Ltd. develops, markets, and supplies pharmaceutical and medical products throughout Canada. RGR offers: skin care, anti-aging, moisture retention, facial oil control, and topical cream products. The company distributes its products under: OBAGI® NuDerm System; OBAGI® ELASTIderm™; ELASTIderm™ Decolletage System; ELASTILash ™; OBAGI® C System; OBAGI® Professional-C Serums; OBAGI® CLENZIderm™; OBAGI® Rosaclear™; Priori® Skin Care; CoffeeBerry®; Advanced AHA’s; Idebenone; AFAs; MAXILENE; and Clarex® . Exclusive cosmeceutical brands recognised worldwide.

RGR Pharma Inc. is headquartered in LaSalle, Canada. 103 Crystal Harbour Drive LaSalle, Ontario N9J 3R6 Canada

Please contact RGR Pharma Inc. for the nearest OBAGI® location that sells ELASTILash™. Telephone: 519-734-6600 Fax: 509-272-9501

RgrOdet@aol.com www.rgrpharma.com

(1.) Data on file. No evidence of eyelid darkening or change in iris pigmentation1 (Reference: 1. OMP, Inc. Data on file.) ELASTILash™should not be used for children under 3 years of age and should not be used on bruised, peeling, injured or infected eyelids. Store at room temperature and keep away from direct sunlight. © SDA Publishing Inc.

© SDA Publishing Inc. All rights reserved. Please read our Privacy Policy.